Karachi: IBL HealthCare Ltd. (IBLHL) announced a 6% year-on-year increase in profit for the fiscal year 2026, as detailed in their recent corporate briefing. The company's profit reached PkR220 million, translating to earnings per share of PkR2.2, up from PkR208 million (EPS: PkR2.1) in the same period last year. This increase was attributed primarily to the expansion of gross margins.

According to AKD Securities Limited, IBLHL's topline revenue rose to PkR4.6 billion in FY26 compared to PkR4.3 billion in the previous fiscal year, marking a 7% increase. This growth was driven by enhanced market availability, strategic promotions, and effective execution of government tenders.

Additionally, the management underscored that when excluding PkR312 million from discontinued portfolios in FY25, revenue from ongoing operations saw an approximate 15% year-on-year increase, rising from PkR4.0 billion to PkR4.6 billion. This reflects an improvement in the company's core business performance.